Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
Abou-Alfa, Ghassan K, Meyer, Tim, Cheng, Ann-Lii, El-Khoueiry, Anthony B, Rimassa, Lorenza, Ryoo, Baek-Yeol, Cicin, Irfan, Merle, Philippe, Chen, YenHsun, Park, Joong-Won, Blanc, Jean-Frederic, Bolondi, Luigi, Klümpen, Heinz-Josef, Chan, Stephen L, Zagonel, Vittorina, Pressiani, Tiziana, Ryu, Min-Hee, Venook, Alan P, Hessel, Colin, Borgman-Hagey, Anne E, Schwab, Gisela, Kelley, Robin K
Published in The New England journal of medicine (05.07.2018)
Published in The New England journal of medicine (05.07.2018)
Get full text
Journal Article
833TiPPhase III (COSMIC-312) study of cabozantinib (C) in combination with atezolizumab (A) vs sorafenib (S) in patients (pts) with advanced hepatocellular carcinoma (aHCC) who have not received previous systemic anticancer therapy
Rimassa, L, Cheng, A-L, Braiteh, F, Chaudhry, A, Benzaghou, F, Thuluvath, P, Hazra, S, Borgman-Hagey, A E, Tan, B, Kayali, Z K, Zhu, A X, Kelley, R K
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
678PDOutcomes based on plasma biomarkers for the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in advanced hepatocellular carcinoma (aHCC)
Rimassa, L, Kelley, R K, Meyer, T, Ryoo, B-Y, Merle, P, Park, J-W, Blanc, J-F, Lim, H Y, Tran, A, Borgman-Hagey, A E, Clary, D O, Wang, E, Cheng, A-L, El-Khoueiry, A B, Abou-Alfa, G K
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
The pharmacokinetics (PK) and pharmacodynamics (PD) of ABT-751 in children with recurrent neuroblastoma or other solid tumors
Fox, E., Widemann, B. C., Maris, J. M., Cohn, S. L., Xiong, H., Krivoshik, A. P., Hagey, A. E., Adamson, P. C., Balis, F. M.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article
A phase I trial of ABT-751 and carboplatin (C) in patients (pts) with previously treated non-small cell lung cancer (NSCLC)
Dragnev, K. H., Rigas, J. R., Disalvo, W. M., Simeone, S. A., Hagey, A. E., Gordon, G. B., Dmitrovsky, E.
Published in Journal of clinical oncology (20.06.2006)
Published in Journal of clinical oncology (20.06.2006)
Get full text
Journal Article
Preliminary phase 2 results of ABT-751 in subjects with advanced renal cell carcinoma (RCC)
Hagey, A. E., Figlin, R. A., Moldawer, N., Sosman, J. A., Chi, K. N., Medina, D. M., Meek, K. A., Cernohous, P., Gordon, G. B.
Published in Journal of clinical oncology (01.06.2005)
Published in Journal of clinical oncology (01.06.2005)
Get full text
Journal Article
Phase I trial and pharmacokinetic (PK) study of ABT-751, an orally bioavailable tubulin binding agent, in pediatric patients with refractory solid tumors
Cho, S. Y., Adamson, P. C., Hagey, A. E., Widemann, B. C., Maris, J. M., Fox, E., Medina, D., Cui, Y., Gordon, G. B., Balis, F. M.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article
Phase I trial and pharmacokinetic (PK) study of ABT-751, an orally bioavailable tubulin binding agent, in pediatric patients with refractory solid tumors
Cho, S. Y., Adamson, P. C., Hagey, A. E., Widemann, B. C., Maris, J. M., Fox, E., Medina, D., Cui, Y., Gordon, G. B., Balis, F. M.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article